"Tertiary care Teaching Hospital, high quality services at affordable rate."

During the past decade, Lourdes Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lourdes Hospital" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Lourdes Hospital" are "Bladder Cancer" (2 trials), "Crohn's Disease" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Lourdes Hospital" in a lesser frequency.

Most popular intervention types in "Lourdes Hospital" are "Biological" (2 trials), "Drug" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (2 trials), "Mycobacterium w" (2 trials), "BCG (Bacillus Calmette-Guerin)" (1 trials), "Placebo" (1 trials) and "Placebo to match filgotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lourdes Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Lourdes Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Lourdes Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lourdes Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".